Cerebrospinal fluid (CSF) biomarkers can present a challenge in neuroscience research because CSF samples are difficult to obtain. This creates a need for blood-based biomarkers. However, identifying them is limited by the sensitivity of standard immunoassays.
Ultrasensitive Single Molecule Counting (SMC®) immunoassay technology enables low-abundant biomarker measurement in a variety of biofluids such as serum, plasma, and CSF. These kits measure biomarkers such as Total Tau, Amyloid Beta, Brain-Derived Neurotrophic Factor (BDNF), and more with unparalleled sensitivity and precision.
Discover more at SigmaAldrich.com/smc-neuro.
For Research Use Only. Not For Use In Diagnostic Procedures.
MilliporeSigma is the U.S. and Canada Life Science business of Merck KGaA, Darmstadt, Germany.
More Information